Transepithelial corneal cross-linking assisted by two continuous cycles of iontophoresis for progressive keratoconus in adults: retrospective 5-year analysis
Open Access
- 29 July 2020
- journal article
- research article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 259 (1) , 239-246
Abstract
Purpose: The aim of this study is to compare the long-term effects of transepithelial corneal crosslinking with two continuous cycles of iontophoresis (EI-CXL) and conventional corneal crosslinking (C-CXL) in adults with progressive keratoconus. Methods: A retrospective analysis was conducted in adults who underwent C-CXL or EI-CXL between 2013 and 2015. Visual acuity, corneal tomography, anterior segment optical coherence tomography, in vivo corneal confocal microscopy (IVCM), and endothelial cell count (ECC) were performed preoperatively and 5 years postoperatively. Results: Sixty-eight patients with a mean age of (24.3 ± 3.8) years were included, 34 for each group. After CXL, UCVA or BCVA remained stable, while the spherical diopter, cylinder diopter, spherical equivalent, and Kmax significantly decreased at 1, 2, and 3 years in both groups than baseline (P < 0.05). No significant differences were found in any refractive or tomographic parameters as well as the minimal corneal thickness between groups during follow-up. At 5 years, Kmax was slightly higher in EI-CXL group (58.16 ± 6.28) than that of C-CXL group (57.46 ± 4.98). At 3 and 5 years, the minimal corneal thickness in C-CXL group was still significantly lower than baseline (P < 0.05). IVCM demonstrated the demarcation zone at a mean depth of (302.0 ± 41.7) μm after C-CXL, and at (251.2 ± 28.1) μm after EI-CXL (P < 0.001). Keratocyte repopulation was detectable at all follow-up timepoint in both groups. Postoperative complications including progression were recorded in 6 patients (11.7%) after C-CXL and 3 patients (8.8%) after EI-CXL. ECC remained stable in both groups. Conclusion: EI-CXL showed approximate efficacy with C-CXL in stabilizing progressive keratoconus in adults. EI-CXL has the potential to be a preferable transepithelial protocol.Keywords
Funding Information
- National Natural Science Foundation of China (81570815, 81570816)
- Xiamen Science and Technology Program for Public Wellbeing (3502Z20174003)
- Xiamen Medical and Health Project (3502Z20189024)
- Huaxia Translational Medicine Fund for Young Scholars (2018-A-006)
- Research Project of Health and Family Planning for Youth in Fujian Province (2017-2-117)
This publication has 30 references indexed in Scilit:
- Clinical and microstructural changes with different iontophoresis-assisted corneal cross-linking methods for keratoconusInternational Journal of Ophthalmology, 2019
- Efficacy of iontophoresis-assisted epithelium-on corneal cross-linking for keratoconusInternational Journal of Ophthalmology, 2018
- Corneal Collagen Cross-Linking ComplicationsSeminars in Ophthalmology, 2017
- Conventional and Iontophoresis Corneal Cross-Linking for KeratoconusCornea, 2017
- A study of stromal riboflavin absorption in ex vivo porcine corneas using new and existing delivery protocols for corneal cross‐linkingActa Ophthalmologica, 2015
- [Transepithelial iontophoresis corneal collagen cross-linking for progressive keratoconus: one year results].2015
- Transepithelial versus epithelium-off crosslinking in adults with progressive keratoconusJournal of Cataract & Refractive Surgery, 2015
- Transepithelial Riboflavin Absorption in an Ex Vivo Rabbit Corneal ModelInvestigative Ophthalmology & Visual Science, 2015
- Corneal Cross-Linking as a Treatment for KeratoconusOphthalmology, 2013
- Persistent Corneal Edema after Collagen Cross-Linking for KeratoconusAmerican Journal of Ophthalmology, 2012